Traditional Chinese Medicine Oral Liquids and Mouthwashes for Radiation-induced Oral Mucositis in Head and Neck Cancer Patients
Traditional Chinese Medicine Oral Liquids and Mouthwashes for Radiation-induced Oral Mucositis in Head and Neck Cancer Patients: A Randomized Controlled Trial
West China Hospital
118 participants
Mar 20, 2026
INTERVENTIONAL
Conditions
Summary
Evaluate the efficacy and safety of traditional Chinese medicine oral liquid and mouthwash in the treatment of radiotherapy induced oral mucositis in patients with head and neck malignancies
Eligibility
Inclusion Criteria6
- Patients pathologically diagnosed with non-metastatic head and neck malignant tumors;
- Age range: 18 to 65 years old (including 18 and 65 years old);
- Eastern Cooperative Oncology Group performance status of ≤2;
- Radiotherapy or concurrent chemoradiotherapy is required;
- The main organ functions well;
- Sign informed consent.
Exclusion Criteria6
- Allergic constitution (such as those known to be allergic to two or more drugs);
- Patients who plan to use drugs that can cause or worsen oral mucosal inflammation (such as anti EGFR monoclonal antibodies, immune checkpoint inhibitors, etc.) after the start of radiotherapy;
- Use of antibiotics, antifungal drugs, or antimicrobial mouthwash within 1 month of the study;
- Poor oral hygiene and/or severe periodontal diseases;
- History of head and neck radiotherapy;
- Deemed unsuitable for the study by the investigators (concomitant with any other severe diseases).
Interventions
Classical traditional Chinese medicine (TCM) formulations provided as an oral liquid and a herbal mouthwash
A placebo matched in color, odor, and taste to the Qingying oral liquid and the modified Da Huang-Huang Lian Xiexin mouthwash, but containing no active medicinal ingredients.
All subjects underwent radical radiotherapy
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07282483